(Q44771917)

English

Toxicity of fludarabine and cyclophosphamide with or without rituximab as initial therapy for patients with previously untreated mantle cell lymphoma: results of a randomised phase II study

scientific article published in February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 December 2017

Toxicity of fludarabine and cyclophosphamide with or without rituximab as initial therapy for patients with previously untreated mantle cell lymphoma: results of a randomised phase II study (English)

1 reference

Europe PubMed Central

6 December 2017

mantle cell lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

David Linch

1 reference

Europe PubMed Central

6 December 2017

author name string

Heather E Eve

1

1 reference

Europe PubMed Central

6 December 2017

Wendi Qian

3

1 reference

Europe PubMed Central

6 December 2017

Moira Ross

4

1 reference

Europe PubMed Central

6 December 2017

John F Seymour

5

1 reference

Europe PubMed Central

6 December 2017

Paul Smith

6

1 reference

Europe PubMed Central

6 December 2017

Lindsey Stevens

7

1 reference

Europe PubMed Central

6 December 2017

Simon A J Rule

8

1 reference

Europe PubMed Central

6 December 2017

publication date

1 February 2009

1 reference

Europe PubMed Central

6 December 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

6 December 2017

50

1 reference

Europe PubMed Central

6 December 2017

211-215

1 reference

Europe PubMed Central

6 December 2017

2

1 reference

Europe PubMed Central

6 December 2017

Cyclophosphamide/fludarabine (CF) is active in the treatment of mantle cell lymphoma.

1 reference

https://api.crossref.org/works/10.1080%2F10428190802688509

21 January 2018

Superior quality and duration of responses among patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide with or without rituximab compared with prior responses to CHOP.

1 reference

https://api.crossref.org/works/10.1080%2F10428190802688509

21 January 2018

The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle

1 reference

https://api.crossref.org/works/10.1080%2F10428190802688509

21 January 2018

Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F10428190802688509

21 January 2018

A new model for predicting infectious complications during fludarabine-based combination chemotherapy among patients with indolent lymphoid malignancies.

1 reference

https://api.crossref.org/works/10.1080%2F10428190802688509

21 January 2018

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.

1 reference

https://api.crossref.org/works/10.1080%2F10428190802688509

21 January 2018

Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: res

1 reference

https://api.crossref.org/works/10.1080%2F10428190802688509

21 January 2018

Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries

1 reference

https://api.crossref.org/works/10.1080%2F10428190802688509

21 January 2018

Identifiers

10.1080/10428190802688509

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44771917&oldid=2040265903"